EXACT Sciences Corporation (EXAS NASDAQ) stock market data APIs
$53.6527
0.46(0.9%)
as of September 15, 2025
Try our APIs with
free plan!
EXACT Sciences Corporation Financial Data Overview
Price chart is built with
Anychart
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. It offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The company also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Riskguard Test, a hereditary cancer test to understand their inherited risk of cancer. Its pipeline focus on advancing screening and diagnostic products, including risk assessment, screening and prevention, early disease diagnosis, adjuvant and/or neoadjuvant disease treatment, metastatic disease treatment selection, and recurrence monitoring. The company has license agreements with MAYO Foundation for Medical Education and Research and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.
Prev. Close
53.6527
Open
54.1116
High
54.2092
Low
53.0974
52 wk Range
38.8118-72.83
Market Cap
10 212 M
Shares Outstanding
189 M
Revenue
2 940 M
EPS
-0.01
Beta
1.049
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with EXACT Sciences Corporation (top by weight)
Ticker
100-day Price Change
Weight
MDEV.US
First Trust Exchange-Traded Fund VI - First Trust Indxx Medical Devices ETF
0.02
(0.12%)
2.24
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get EXACT Sciences Corporation data using free add-ons & libraries
Get EXACT Sciences Corporation Fundamental Data
EXACT Sciences Corporation Fundamental data includes:
- Net Revenue: 2 940 M
- EBITDA: 78 282 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-06
- EPS/Forecast: -0.13
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
EXACT Sciences Corporation News
New
3 Stocks That Could Be Undervalued By As Much As 29.5%
As the Nasdaq and S&P 500 reach record highs, investors are closely watching the Federal Reserve's upcoming interest rate decision, which could influence market dynamics. In this environment of height...
Why Exact Sciences (EXAS) is a Top Growth Stock for the Long-Term
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. While you may have an investing style you rely on...
Exact Sciences Launches Cancerguard MCED Blood Test, Stock Climbs
Exact Sciences Corporation EXAS has launched the Cancerguard test, a new multi-cancer early detection (MCED) blood test now offered as a laboratory-developed test (LDT) in the United States. Cancergua...
Exact Sciences price target raised to $85 from $65 at Craig-Hallum
Craig-Hallum raised the firm’s price target on Exact Sciences (EXAS) to $85 from $65 and keeps a Buy rating on the shares. The firm would be a buyer of Exact Sciences. With the Freenome deal in plac...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
